THG is currently the most frustrating company on the London Stock Exchange. You’ve likely seen the headlines. One day it’s a "tech darling" destined to redefine global e-commerce, and the next, it’s a cautionary tale about corporate governance and bloated ambitions. If you’re looking for a simple "yes" or "no" on whether the stock is about to moon, you’re asking the wrong question. The real story isn't about whether Matthew Moulding can post another defiant Instagram reel. It's about whether the massive demerger plan actually simplifies a business that has spent years being intentionally over-complicated.
Most people tracking THG (formerly The Hut Group) get bogged down in the drama. They focus on the falling share price or the friction with institutional investors. But if you want to understand if THG is actually about to make gains, you have to look at the three-headed monster the company has become. You have Nutrition (Myprotein), Beauty (Lookfantastic and Cult Beauty), and Ingenuity (the tech platform). For a long time, these three were shoved together in a way that made it impossible for the market to value them properly. That’s finally changing, and it’s the only thing that matters right now.
The Demerger is the Only Catalyst That Matters
For years, the bear case against THG was that it was a "black box." Investors hated that the high-margin beauty business was subsidizing the capital-intensive rollout of the Ingenuity platform. It felt messy. It felt risky. Now, the company is finally moving toward a breakup that could unlock the value everyone has been screaming about since the 2020 IPO.
The plan to spin off the nutrition division is a massive deal. Myprotein is a powerhouse. It isn’t just a website selling bags of whey protein anymore. It’s a global lifestyle brand with licensing deals and presence in major physical retailers. When you isolate Myprotein, it looks like a high-growth consumer staple brand. When it’s buried inside the THG conglomerate, it gets a "conglomerate discount." By separating these entities, Moulding is forcing the market to look at the actual cash flow of each segment.
If you’re holding THG, you’re basically betting that the sum of the parts is worth significantly more than the current market cap. Historically, that’s been true for many distressed UK firms. The problem is timing. These structural changes don't happen overnight, and the market has a very short memory for "potential" when the current balance sheet still shows significant debt.
Why Ingenuity is Still the Wild Card
Ingenuity is the part of the business that was supposed to make THG a tech giant. It’s an end-to-end e-commerce solution. In theory, a brand like Coca-Cola or Kraft Heinz pays THG to handle everything from the website to the shipping and the marketing. It sounds brilliant. In practice, it’s been a hard sell to a skeptical City of London.
Critics argue that Ingenuity isn't a "tech" platform at all, but rather a high-cost logistics business with a website frontend. That distinction is vital. Tech companies get high multiples. Logistics companies don't. To see real gains, THG needs to prove that Ingenuity can scale without needing a new warehouse every time they sign a client. We’re starting to see some movement here with more "software-only" deals, but the revenue mix still leans heavily on the physical side of things.
The recent move to the "Premium" segment of the London Stock Exchange is a step toward fixing the trust gap. It means more oversight and more index inclusion. It sounds boring, but for a stock that has been treated like a pariah by big index funds, it’s a vital plumbing upgrade.
The Matthew Moulding Factor
You can't talk about THG without talking about the founder. Moulding is a polarizing figure. He’s outspoken, he’s aggressive, and he clearly feels the London market has treated his "baby" unfairly. Some investors love that passion. They see a founder-led company with skin in the game. Others see a liability.
The reality is probably somewhere in the middle. His "Special Share" which gave him ultimate control was a massive red flag for institutional investors for years. Now that he’s relinquished that, the path is clearer for big pension funds to start buying in again. But the culture of the company remains intensely focused on his vision. If you’re investing here, you’re essentially backing a guy who is currently at war with the status quo of British finance.
Looking at the Numbers Without the Hype
Let's be blunt about the financials. THG has struggled with profitability on a statutory basis for a long time. They talk about "Adjusted EBITDA" constantly, but the market is tired of adjustments. They want to see actual pre-tax profit and free cash flow.
The good news is that the capital expenditure peak is likely behind them. They’ve built the warehouses. They’ve integrated the acquisitions like Cult Beauty. Now, they just need to run the machine. In the last few reporting cycles, we’ve seen margins in the Beauty and Nutrition segments start to stabilize despite the massive inflation in raw ingredients (like the price of whey).
- Revenue is steady, but the growth has slowed from the pandemic highs.
- Debt levels are manageable but require constant monitoring.
- The valuation is currently at a fraction of its IPO price, suggesting most of the "bad news" is already baked in.
Stop Following the Retail Herd
If you’re reading Discord chats or Twitter threads about "short squeezes," you’re going to lose money. THG isn't a meme stock, even if some people try to trade it like one. It’s a complex recovery play in a very difficult retail environment.
The real gains won't come from a sudden viral moment. They’ll come from the successful execution of the demerger and the continued pivot toward profitability. The UK market is notoriously harsh on growth companies that don't produce immediate dividends, which is why THG has suffered more than its peers in the US would have.
How to Approach THG Right Now
If you’re looking at THG, stop looking at the 15-minute charts. Look at the 2026 horizon. Ask yourself if you believe Myprotein is a world-class brand. If the answer is yes, then the current valuation of the entire group seems low. But you have to be prepared for volatility. This is a stock that moves 5% on a random Tuesday because of a rumor.
Check the regulatory filings for "Director Buys." When the people running the company are buying shares with their own money, it's usually a better signal than any analyst report. Moulding has put his money where his mouth is more than once.
Watch the interest rate environment closely. High rates kill companies with debt and long-term "growth" stories. If rates start to trend down, THG will likely be one of the first beneficiaries as investors regain their appetite for riskier UK equities. Don't buy the hype, but don't ignore the structural changes that are finally happening behind the scenes. The "gains" people are looking for are possible, but they'll be earned through boring corporate restructuring, not magic.
